Lipocine Inc.
LPCN
$7.67
$0.385.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.63% | -44.48% | -18.27% | -204.64% | 180.32% |
| Total Depreciation and Amortization | 6.38% | -12.42% | 3.21% | 0.00% | 83.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -169.43% | -37.34% | 140.63% | 155.41% | 88.35% |
| Change in Net Operating Assets | -428.76% | -38.52% | 305.43% | -82.28% | 82.84% |
| Cash from Operations | 2.22% | -58.29% | 4.22% | -215.71% | 160.08% |
| Capital Expenditure | -- | -- | -- | -- | 87.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 124.08% | -84.41% | 610.15% | -214.40% | -30.06% |
| Cash from Investing | 124.08% | -84.41% | 610.15% | -215.90% | -25.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,777.28% | 86.90% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,777.28% | 86.90% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 160.89% | -179.68% | 194.32% | -215.77% | 236.05% |